Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $22.2 million.

  • BIO-TECHNE's Net Income towards Common Stockholders rose 13.65% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year decrease of 75.73%. This contributed to the annual value of $22.2 million for FY2025, which is 82.61% down from last year.
  • Latest data reveals that BIO-TECHNE reported Net Income towards Common Stockholders of $22.2 million as of FY2025, which was down 82.61% from $127.9 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Net Income towards Common Stockholders ranged from a high of $263.1 million in FY2022 and a low of $22.2 million during FY2025.
  • For the 3-year period, BIO-TECHNE's Net Income towards Common Stockholders averaged around $135.3 million, with its median value being $127.9 million (2024).
  • In the last 5 years, BIO-TECHNE's Net Income towards Common Stockholders skyrocketed by 135.81% in 2022 and then plummeted by 82.61% in 2025.
  • Yearly analysis of 5 years shows BIO-TECHNE's Net Income towards Common Stockholders stood at $111.6 million in 2021, then skyrocketed by 135.81% to $263.1 million in 2022, then declined by 2.83% to $255.6 million in 2023, then plummeted by 49.95% to $127.9 million in 2024, then crashed by 82.61% to $22.2 million in 2025.